FTXH ETF

FTXH ETF
$41.66
See how much of FTXH you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

Returns Overview

1 Month
+1.83%
3 Months
+15.09%
6 Months
+14.98%
YTD
+17.72%
1 Year
+52.38%
3 Years (annualized)
+15.20%
5 Years (annualized)
+9.53%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would FTXH have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
Nasdaq US Smart Pharmaceuticals Index(NQSSPH)
This ETF (YTD)
+17.72%
Peer Avg (YTD)
+6.74%
vs Peers
+10.98%

FTXH ETF Performance

FTXH performance across multiple time periods: 1-month 1.83%, YTD 17.72%, 1-year 52.38%, 3-year 15.20%, 5-year 9.53%.

FTXH returns outperform the peer average of 6.74% YTD. With an expense ratio of 0.60%, investors should weigh costs against performance when evaluating this ETF.

FTXH vs another fund shows side-by-side returns. FTXH alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+1.83%N/A
3 Months+15.09%N/A
6 Months+14.98%N/A
1 Year+52.38%N/A
3 Years+15.20%N/A
5 Years+9.53%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized